The recent arrival of this new formulation represents a potentially significant advancement in the treatment of type 2 the condition . This therapy builds upon the prior success of lower dosages , showing impressive results in reducing blood glycemic control and aiding weight reduction . Researchers are investigating its overall impact on heart out